In this study, we present a case of late-puerperal onset of thrombohemorrhagic complications in a 33-yr-old woman with known antiphospholipid syndrome (APS) and heterozygosity for factor V Leiden gene mutation. Antithrombotic prophylaxis with low-molecular-weight (LMW) heparin was given since the 12th gestational week. Pregnancy and cesarean delivery were uncomplicated. Five weeks postpartum, the patient developed a severe hemorrhagic diathesis with marked thrombocytopenia accompanied by vaginal, nasal and cutaneous bleeding. A variety of autoimmune phenomena were also detected, partly at clinical presentation and partly later on, despite ongoing steroid treatment. Platelet counts recovered to normal values within a few weeks secondary to high-dose steroids and intravenous immunoglobulin administration. An ultrasound of both legs, performed because of persistent complaint of moderate calf pain, revealed bilateral deep venous thromboses (DVT). The clinical and biochemical findings were not consistent with thrombotic thrombocytopenic purpura (TTP), heparin-induced thrombocytopenia (HIT) or the 'hemolysis, elevated liver enzymes and low platelet syndrome' (HELLP). The diagnostic criteria for systemic lupus erythematosus (SLE) were not fulfilled either. The complex of thrombohemorrhagic complications and autoimmune phenomena seen in this case is unusual and not previously described in the late puerperal stage of APS-related pregnancies.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2004.00319.xDOI Listing

Publication Analysis

Top Keywords

thrombohemorrhagic complications
12
late puerperal
8
antiphospholipid syndrome
8
autoimmune phenomena
8
puerperal thrombohemorrhagic
4
complications patient
4
patient antiphospholipid
4
syndrome study
4
study case
4
case late-puerperal
4

Similar Publications

Unlabelled: A high level of hemoglobin and hematocrit is one of the most important laboratory indicators of polycythemia vera (PV). Nevertheless, in some cases, these indicators may be normal or below the norm. This form of the disease is called latent or masked PV (LPV).

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed haematological oncology patients with severe thrombocytopenia, focusing on factors influencing bleeding and thrombosis risks in those not on anticoagulants.
  • Out of 446 patients, it was found that specific clinical features, such as leukemia presence and central venous catheter use, were linked to bleeding, while histories of thrombosis and certain treatments correlated with thrombosis risk.
  • Logistic regression revealed lymphoma and minimum platelet count as protective against bleeding, while history of thrombosis and catheter use were identified as significant risk factors for thrombosis.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of preoperative anticoagulation (AC) on perioperative outcomes in patients undergoing sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB).
  • Analyzing data from the 2015-2021 MBSAQIP database, it was found that a small percentage of patients on AC experienced higher rates of complications such as anastomotic leaks and gastrointestinal bleeding compared to those not on AC.
  • Overall, the findings suggest that patients on preoperative AC faced increased postoperative complications and longer hospital stays, emphasizing the need for careful management in these cases.
View Article and Find Full Text PDF

Importance: Patients with trauma exhibit a complex balance of coagulopathy manifested by both bleeding and thrombosis. Antithrombin III is a plasma protein that functions as an important regulator of coagulation. Previous studies have found a high incidence of antithrombin III deficiency among patients with trauma.

View Article and Find Full Text PDF

Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation.

Dig Liver Dis

December 2024

Department of Medicine (DIMED), University of Padova, Padova, Italy; First Chair of Internal Medicine and Thrombotic and Haemorrhagic Disease Unit, Padova University Hospital, Padova, Italy. Electronic address:

Introduction: Factor XI (FXI) is associated with thrombosis in patients without liver disease, but it alterations and prognostic value in cirrhosis are uncertain.

Patients And Methods: We studied a prospective cohort of cirrhosis patients determining FXI and its association with portal vein thrombosis (PVT), bleeding, and hepatic decompensation/ACLF during 1-year follow-up. Odds ratios (OR) and 95 % CIs were calculated using logistic regression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!